Anacura aquires Ohmx.bio
Merger within Ghent, Belgium: Anacura acquires OHMX.bio (both residing in neighborhood), adding multi-omics for drug discovery and diagnostics to its services.
Anacura, a Ghent-based company offering medical and pharmaceutical analytical services, announces the acquisition of OHMX.bio, a also Ghent-based University spin-off specialized in advanced -omics technology.
The acquisition expands the existing anacura group activities at AnaBioTec and Labo Nuytinck towards drug discovery and diagnostics research.
Anacura is offering personalised and evidence-based laboratory solutions. The group supports health care providers and patients through medical analyses at Labo Nuytinck and assists pharmaceutical and biotech companies with end-to-end drug development analytics at AnaBioTec. Anacura CEO Griet Nuytinck says: “The acquisition of OHMX.bio is the next step in anacura’s aim to remain a frontrunner in innovative healthcare services, complementing ongoing initiatives within our existing business units. With the acquisition, we bring in a company with deep scientific expertise, enabling us to provide an even stronger service offering to the biotech community in Belgium and beyond.”
Established in 2019 as a Ghent University spin-off, OHMX.bio operates as a study design company, specializing in cutting-edge -omics technologies for discovery and (pre)clinical studies. The company combines multi-omic technologies, such as next-generation sequencing, in combination with advanced bio-informatics to speed up the discovery process and quality control of biologics and advanced therapy medicinal products (ATMPs) such asmRNA vaccines and CAR-T cells. OHMX.bio CEO/CSO Gerben Menschaert adds: “Our activities complement the current service offering within the anacura group and, importantly, we share the same values, mission and drive for quality, scientific excellence, and a tailored personal approach.” Menschaert is one of the co-founders of OHMX.bio and is a professor at the Lab of Bioinformatics and Computational Genomics at Ghent University.
Anacura has more than 250 employees based in Evergem (Ghent) and Bruges.
